Substance Use Disorder E026
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14
Rulebase for drug dependence and drug abuse
<div><h5><strong>Current RMA </strong>Instruments</h5><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2017/059.pdf" target="_blank">Reasonable Hypothesis SOP </a></address></td><td>59 of 2017</td></tr><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2017/060.pdf" target="_blank">Balance of Probabilities SOP</a></address></td><td>60 of 2017</td></tr></tbody></table><h5>Changes from previous Instruments</h5><p><drupal-media data-entity-type="media" data-entity-uuid="0fe799c7-3ba5-4173-bd46-604a860dba46" data-view-mode="wysiwyg"></drupal-media></p><h5><strong>ICD Coding</strong></h5><ul><li>ICD-9-CM Codes: 304, 305.2-305.8</li><li>ICD-10-AM Codes: <span>F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0</span></li></ul><h5>Brief description</h5><p>Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.</p><h5>Confirming the diagnosis</h5><p>A report from a specialist psychiatrist that conforms with the Repatriation Commission <a href="/node/21517" target="_blank"><i>Guidelines for Psychiatric Compensation Claims</i></a><i> </i>is required for diagnosis.</p><h5><strong>Additional diagnoses covered by SOP</strong></h5><p>Substance use disorder involving:</p><ul><li>Amphetamines</li><li>Cannabis</li><li>Cocaine</li><li>Hallucinogens</li><li>Inhalants (hydrocarbon based)</li><li>Opioids</li><li>Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)</li><li>Tobacco</li></ul><h5>Conditions not covered by SOP</h5><ul><li>Alcohol use disorder*</li><li>Caffeine-related disorders</li><li>Chronic solvent encephalopathy*</li><li>Substance intoxication</li><li>Substance-induced mental disorders</li></ul><p>* another SOP applies</p><h5>Clinical onset</h5><p>Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.</p><h5>Clinical worsening</h5><p>Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.</p><p> </p><p> </p><p> </p><p> </p><p><br> </p><p> </p></div>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rulebase-drug-dependence-and-drug-abuse
A category 1A stressor
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14/rulebase-drug-dependence-and-drug-abuse/category-1a-stressor
A category 1B stressor
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14/rulebase-drug-dependence-and-drug-abuse/category-1b-stressor
A clinically significant psychiatric condition
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14/rulebase-drug-dependence-and-drug-abuse/clinically-significant-psychiatric-condition
A serious medical illness or injury
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14/rulebase-drug-dependence-and-drug-abuse/serious-medical-illness-or-injury
No appropriate clinical management for drug dependence or drug abuse
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14/rulebase-drug-dependence-and-drug-abuse/no-appropriate-clinical-management-drug-dependence-or-drug-abuse
Prescribed medication
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14/rulebase-drug-dependence-and-drug-abuse/prescribed-medication
Severe childhood abuse
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14/rulebase-drug-dependence-and-drug-abuse/severe-childhood-abuse
The death of a significant other
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2017 |
| Balance of Probabilities SOP | 60 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 304, 305.2-305.8
- ICD-10-AM Codes: F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F19.2, F55.0
Brief description
Substance use disorder is a DSM-5 diagnosis that replaced the DSM-IV categories of drug dependence and drug abuse. The condition involves clinically significant psychosocial impairment and problematic behaviors related to obtaining, using, or recovering from a substance.
Confirming the diagnosis
A report from a specialist psychiatrist that conforms with the Repatriation Commission Guidelines for Psychiatric Compensation Claims is required for diagnosis.
Additional diagnoses covered by SOP
Substance use disorder involving:
- Amphetamines
- Cannabis
- Cocaine
- Hallucinogens
- Inhalants (hydrocarbon based)
- Opioids
- Prescription drugs (sedatives, hypnotics, anxiolytics, tranquillisers)
- Tobacco
Conditions not covered by SOP
- Alcohol use disorder*
- Caffeine-related disorders
- Chronic solvent encephalopathy*
- Substance intoxication
- Substance-induced mental disorders
* another SOP applies
Clinical onset
Clinical onset is when the the diagnostic criteria can first be said (by a medical practitioner) to have been fulfulled. It will not be when the substance was first used.
Clinical worsening
Evidence of worsening of the condition may be shown by an increase in the number of symptoms/diagnostic criteria or a more severe pattern of symptoms or problems resulting from substance use. Establishing that any worsening represents a permanent clincial worsening will be more difficult, as there may be fluctuations in the pattern of substance use over time.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/substance-use-disorder-e026-f112f122f132f14/rulebase-drug-dependence-and-drug-abuse/death-significant-other